JCR Pharmaceuticals4552 
$4.53-1.23%24h
-1.23%24h
Global rank10649
Market cap$562.97M
Change 7d1.10%
YTD Performance-44.86%
SP500 benchmarkUnderperform
P/E0.15
P/S2.33
Revenue$241.51M
Earnings$26.63M
Dividend yield-
Main Sector
Healthcare
JCR Pharmaceuticals 4552 Total Debt
4552 Total Debt in 2022: $38.68M
According to JCR Pharmaceuticals latest financial reports the total debt is $38.68M, an increase of 86.44% to 2022. At the end of 2022 company had $20.75M total debt. This figure represents the debts and financial obligations that JCR Pharmaceuticals combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
JCR Pharmaceuticals 4552 Total Debt History from 2023 to 2022
-
Value:-
4552 Total Debt by year
| Year | Total debt | Change |
|---|---|---|
| 2023 | $38.68M | 86.44% |
| 2022 | $20.75M | -43.81% |
| 2021 | $36.92M | 38.16% |
| 2020 | $26.72M | 97.61% |
| 2019 | $13.52M | - |
View the Top Total Debt Stocks 
